Evidence map›Paper›PMID 26674763›Full record

Trial reportThe Journal of nutrition2016

Absorption and Distribution Kinetics of the 13C-Labeled Tomato Carotenoid Phytoene in Healthy Adults.

Nancy E Moran, Janet A Novotny, Morgan J Cichon, Kenneth M Riedl, Randy B Rogers, Elizabeth M Grainger, Steven J Schwartz, John W Erdman, Steven K Clinton

Registry-linked trialOpen access · bronzeAbstract readClinical TrialComparative Study
In one paragraph

Trial report in The Journal of nutrition, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01692340 (Novel 13C Carotenoids for Absorption and Metabolism Studies in Humans.), which is not on this map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01692340 phase1 / phase2completednot on this map

Novel 13C Carotenoids for Absorption and Metabolism Studies in Humans.

TypeinterventionalSponsorOhio State University Comprehensive Cancer CenterRan2012 to 2013Enrolled12ConditionsHealthyArmsIsotopically labeled lycopene, phytoene or phytofluene
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Recent advances in carotenoid absorption, distribution, and elimination.Biochimica et biophysica acta. Molecular and cell biology of lipids · 2025
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Nancy E MoranThe Ohio State University Comprehensive Cancer Center.ORCID http://orcid.org/0000-0001-7281-9187
Janet A NovotnyHuman Nutrition Research Center, USDA, Beltsville, MD; and.ORCID http://orcid.org/0000-0002-9121-886X
Morgan J CichonDepartment of Food Science and Technology, and.ORCID http://orcid.org/0000-0001-9379-0264
Kenneth M RiedlThe Ohio State University Comprehensive Cancer Center, Department of Food Science and Technology, and.
Randy B RogersDepartment of Food Science and Human Nutrition and Division of Nutritional Sciences, University of Illinois, Urbana, IL.
Elizabeth M GraingerThe Ohio State University Comprehensive Cancer Center.
Steven J SchwartzThe Ohio State University Comprehensive Cancer Center, Department of Food Science and Technology, and.ORCID http://orcid.org/0000-0002-1427-5780
John W ErdmanDepartment of Food Science and Human Nutrition and Division of Nutritional Sciences, University of Illinois, Urbana, IL.
Steven K ClintonThe Ohio State University Comprehensive Cancer Center, The James Cancer Hospital and Department of Internal Medicine-Division of Medical Oncology, The Ohio State University, Columbus, OH; Steven.Clinton@osumc.edu.
The Ohio State University · USUniversity of Illinois Urbana-Champaign · USBeltsville Human Nutrition Research Center · USThe Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Jennifer A. Woyach · 1985 to 2026
$132.3M
The Ohio State University Center for clinical and Translational ScienceUL1TR001070 · NCATS · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2013 to 2017
$22.6M
Novel 13-C Tomato Carotenoids for Absorption and Metabolism Studies in HumansR21AT005166 · NCCIH · OHIO STATE UNIVERSITY · PI CLINTON, STEVEN K · 2010 to 2012
$659k
NCATS NIH HHS UL1TR001070NCCIH NIH HHS R21AT005166NCI NIH HHS P30 CA016058NCI NIH HHS P30CA016058
6 · The paper itself

Abstract

backgroundPhytoene is a tomato carotenoid that may contribute to the apparent health benefits of tomato consumption. Although phytoene is a less prominent tomato carotenoid than lycopene, it is a major carotenoid in various human tissues. Phytoene distribution to plasma lipoproteins and tissues differs from lycopene, suggesting the kinetics of phytoene and lycopene differ.

objectiveThe objective of this study was to characterize the kinetic parameters of phytoene absorption, distribution, and excretion in adults, to better understand why biodistribution of phytoene differs from lycopene.

methodsFour adults (2 males, 2 females) maintained a controlled phytoene diet (1-5 mg/d) for 42 d. On day 14, each consumed 3.2 mg (13)C-phytoene, produced using tomato cell suspension culture technology. Blood samples were collected at 0, 1-15, 17, 21, and 24 h and 2, 3, 4, 7, 10, 14, 17, 21, and 28 d after (13)C-phytoene consumption. Plasma-unlabeled and plasma-labeled phytoene concentrations were determined using ultra-HPLC-quadrupole time-of-flight-mass spectrometry, and data were fit to a 7-compartment carotenoid kinetic model using WinSAAM 3.0.7 software.

resultsSubjects were compliant with a controlled phytoene diet, consuming a mean ± SE of 2.5 ± 0.6 mg/d, resulting in a plasma unlabeled phytoene concentration of 71 ± 14 nmol/L. A maximal plasma (13)C-phytoene concentration of 55.6 ± 5.9 nM was achieved 19.8 ± 9.2 h after consumption, and the plasma half-life was 2.3 ± 0.2 d. Compared with previous results for lycopene, phytoene bioavailability was nearly double at 58% ± 19%, the clearance rate from chylomicrons was slower, and the rates of deposition into and utilization by the slow turnover tissue compartment were nearly 3 times greater.

conclusionsAlthough only differing from lycopene by 4 double bonds, phytoene exhibits markedly different kinetic characteristics in human plasma, providing insight into metabolic processes contributing to phytoene enrichment in plasma and tissues compared with lycopene. This trial was registered at clinicaltrials.gov as NCT01692340.

Indexed as

DietIntestinal AbsorptionAdultAntioxidantsBiological AvailabilityCarbon IsotopesCarotenoidsFemaleHalf-LifeHumansKineticsLycopeneMaleSolanum lycopersicumTissue Distribution(all-E) phytoeneAntioxidantsCarbon IsotopesCarotenoidsLycopenecarotenoidcompartmental modelingkineticsphytoenetomato

Identifiers

PMID26674763
PMCPMC4725433
OpenAlexW2234745566

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.